Sumampong, Cecilio B.

HRN: 19-19-49  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/04/2023
11/11/2023
IV
500mg
Q8
Intestinal Amoebiasis
Waiting Final Action 
11/09/2023
METRONIDAZOLE 500MG (TAB)
11/09/2023
11/16/2023
ORAL
500mg
TID
Amoebiasis
Waiting Final Action 
11/09/2023
CEFTRIAXONE 1G (VIAL)
11/09/2023
11/16/2023
IV
2 Grams
OD
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: